• Cystatin C, Serum
  • Hemoglobin, Free, Plasma
  • Carcinoembryonic Antigen (CEA), Peritoneal Fluid
  • Chikungunya Virus RNA, Real-Time PCR, Qualitative
  • HDL Cholesterol ( High Density Lipoprotein)
  • Apolipoprotein L1 (APOL1) Genotyping for Chronic Kidney Diseases
  • Valproic Acid, Free and Total, Serum
  • Neisseria gonorrhoeae Nucleic Acid, Liquid Cytology
  • Insulin-Like Growth Factor 2 (IGF-2)
  • Ethanol (Alcohol), Serum
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Guardant360 TissueNext™, Lung and Breast Cancer Therapy Management
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Guardant360 TissueNext™, Lung and Breast Cancer Therapy Management
Medical Test

Clinical Utility
Access to Guardant360 TissueNext™, Lung and Breast Cancer Therapy Management is restricted.
Loading...